Global Artificial Pancreas Device System Market to 2025 - Analysis and Forecasts by Leading Players Defymed, TypeZero Technologies, Insulet, Bigfoot Biomedical,Medtronic, Dexcom, Admetsys, Beta Bionics, Cellnovo, Tandem Diabetes Care

The report analyzes factors affecting artificial pancreas device systems market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key artificial pancreas device systems manufacturing companies along with their SWOT analysis and market strategies.

The major players operating in the artificial pancreas device systems market include Defymed, TypeZero Technologies, Inc., Insulet Corporation, Bigfoot Biomedical, Inc., Medtronic, Dexcom, Inc., Admetsys, Beta Bionics, Cellnovo, and Tandem Diabetes Care.

Get sample PDF copy at: http://bit.ly/2TBnzzQ

The global artificial pancreas device systems market is expected to reach US$ 2,168.1 Mn in 2025 from US$ 481.8 Mn in 2017. The market is estimated to grow with a CAGR of 20.9% from 2018-2025.

Artificial pancreas device systems market is segmented by type and geography. Global artificial pancreas device systems market, based on the type was segmented into control to range, control to target, and threshold-suspended device systems.

Artificial pancreas device system are the devices that closely copy the glucose regulating function of fit pancreas. The device not only monitors the glucose levels in the body, it also automatically adjusts the distribution of insulin to reduce high blood glucose levels and lowers the incidence of low blood glucose with less or no input from the patient. According to the Food and Drug Administration, the use of an artificial pancreas is associated with better control of blood sugar levels for people with type 1 diabetes compared with standard treatment. The report would be of an interest to various stakeholders operating in the artificial pancreas device systems market. These stakeholders include artificial pancreas product manufacturers, vendors, and distributors, research institutes and government organizations, venture capitalists and other government funding organizations, research and consulting firms, healthcare institutions and others.

The objective of the study is to describe, define, and forecast the artificial pancreas device systems market by type and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall market.

The market players are incorporating organic growth strategies such as introduction of new products into the market to sustain their global position in the highly competitive global artificial pancreas device systems market. For instance, in January 2015, Medtronic launched the MiniMed 640G System, which is the advanced system for an artificial pancreas. The MiniMed 640G is developed for helping people with diabetes to attain better glucose control through advanced protection from hypoglycemia.

Inquiry for Discount at: http://bit.ly/2TC2kxN

GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET – MARKET LANDSCAPE 19

3.1 OVERVIEW 19

3.2 MARKET SEGMENTATION 19
3.2.1 Global Artificial pancreas device systems Market – By Type 20
3.2.2 Global Artificial pancreas device systems Market – By Geography 20
3.3 PEST ANALYSIS 22
3.3.1 North America – PEST Analysis 22
3.3.2 Europe– PEST Analysis 24
3.3.3 Asia Pacific– PEST Analysis 26
3.3.4 Middle East And Africa– PEST Analysis 28
3.3.5 South and Central America – PEST Analysis 30

4. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET – KEY MARKET DYNAMICS 32

4.1 KEY MARKET DRIVERS 32

4.1.1 Growing Prevalence of Diabetes 32
4.1.2 Developments by Major Players 33
4.1.3 Rise in Demand for Computerized Systems for Glycemic Control 34
4.2 KEY MARKET RESTRAINTS 35
4.2.1 Availability of Alternatives for Artificial Pancreas Device Systems 35
4.2.2 High Cost of Artificial Pancreas Device Systems 36
4.3 KEY MARKET OPPORTUNITIES 36
4.3.1 Increasing Medical Tourism In Emerging Nations 36
4.4 FUTURE TRENDS 36
4.4.1 Pancreas Cell Implant 37
4.5 IMPACT ANALYSIS 38

Buy Now at: http://bit.ly/2TCvYTu

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.